Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial [Phase 2, Phase 3]
Clinical trial update for a turmeric-based therapy in psoriasis occurring in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis [Phase 2]
Phase 2 trial update evaluating repeat dosing of GSK2982772 in psoriasis, focusing on safety, tolerability, PK/PD, and efficacy; results com…
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis [Phase 1]
A first-in-human Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of IV GSK2831781 in healthy volunteers…
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U) [Phase 4]
Phase 4 clinical trial update on vascular inflammation in psoriasis with ustekinumab has completed and results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Etanercept (Enbrel®) in Psoriasis - Pediatrics [Phase 3]
Phase 3 pediatric trial update for etanercept (Enbrel) in psoriasis completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis [Phase 2]
Phase 2 trial assessing long-term safety, tolerability, and efficacy of AMG 827 in psoriasis was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing BI 655066 to placebo and active comparator (ustekinumab) in moderate to severe chronic plaque psoriasis has complete…
-
EMA safety_alert · 2019-07-12PRAC recommends new measures to avoid dosing errors with methotrexate
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommends new measures to prevent dosing errors with methotrexate, including e…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis [Phase 4]
A Phase 4 trial assessing the effect of brodalumab versus placebo on vascular inflammation in moderate-to-severe psoriasis.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies [Phase 4]
Phase 4 trial update for brodalumab in moderate-to-severe plaque psoriasis patients who failed IL-17A therapies; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: MAP Study: Methotrexate and Adalimumab in Psoriasis [Phase 2, Phase 3]
A trial update for MAP Study investigating methotrexate and adalimumab in psoriasis across Phase 2 and Phase 3, with completed status.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Study of Secukinumab With 2 mL Pre-filled Syringes [Phase 3]
Phase 3 trial of secukinumab using 2 mL pre-filled syringes in psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis [NA]
A terminated clinical trial evaluated acitretin or tazarotene gel with excimer laser for psoriasis; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing risankizumab to placebo and ustekinumab in moderate to severe chronic plaque psoriasis completed with posted results…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating serlopitant for pruritus in plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study [EARLY_Phase 1]
First-in-human Phase 1 safety and pharmacokinetic study of a sustained-release depot tacrolimus.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Adherence in Topical Treatment of Psoriasis [Phase 4]
Phase 4 clinical trial update examining adherence in topical treatment of psoriasis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing risankizumab to adalimumab in moderate-to-severe chronic plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment [Phase 3]
Phase 3 trial update on risankizumab (BI 655066/ABBV-066) in moderate to severe plaque psoriasis with randomized withdrawal and re-treatment…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study [Phase 2]
A Phase 2 real-world study evaluating Chinese herbal medicine for psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update evaluating re-treatment with Cimzia in chronic plaque psoriasis; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin [Phase 2]
Phase 2 trial evaluating topical treatments for modulation of the skin microbiome in psoriatic skin (Psoriasis Vulgaris) completed.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis [Phase 1, Phase 2]
Phase 1/2 clinical trial of GSK2981278 ointment in plaque psoriasis completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis [Phase 3]
Phase 3 trial evaluating secukinumab for moderate to severe psoriasis, focusing on disease severity, psychosocial impact, long-term safety, …
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients [Phase 4]
Phase 4 trial updating on the cardiovascular risk impact of methotrexate alone versus methotrexate with vitamin D in patients with psoriasis…